SweetValueLab
Write for us

Freeport-McMoRan Inc. — Wall Street Analyst Estimates & Price Targets

FCX
NYSEBasic MaterialsCopperCIK 0000831259fcx.comAbout FCX
Last close · Oct 16, 202669.54−0.52 (−0.74%)
Market cap$100.0B

7 firms' latest targets, last 90 days: median $75.00 ($47.00–$88.00), 8% above the last close.

Price and published targets

daily close, 12 months · each dot a target, a firm's latest darker
$40.0$60.0$80.0NovJan 2026MarMayJulSep2025-10-17 · HSBC: $50.02025-10-28 · Scotiabank: $51.02025-11-19 · BMO Capital: $47.02025-11-19 · Scotiabank: $47.02025-12-12 · UBS: $60.02025-12-15 · Morgan Stanley: $53.02025-12-23 · Wells Fargo: $55.02026-01-05 · Jefferies: $68.02026-01-13 · Wells Fargo: $64.02026-01-23 · UBS: $70.02026-01-23 · Bernstein: $54.02026-01-26 · Scotiabank: $70.02026-01-27 · Morgan Stanley: $70.02026-02-20 · Scotiabank: $72.02026-03-27 · UBS: $66.02026-04-14 · Scotiabank: $71.02026-04-15 · Deutsche Bank: $72.02026-04-15 · Wells Fargo: $77.02026-04-23 · Jefferies: $75.02026-04-24 · UBS: $74.02026-04-24 · Morgan Stanley: $66.02026-05-21 · Barclays: $77.02026-05-21 · UBS: $75.02026-06-10 · Bernstein: $58.52026-06-30 · UBS: $77.02026-07-08 · Goldman Sachs: $74.02026-07-15 · Barclays: $80.02026-07-23 · BMO Capital: $78.02026-07-24 · RBC Capital: $73.02026-07-24 · Wells Fargo: $70.02026-07-27 · Barclays: $82.02026-09-09 · Bernstein: $47.02026-10-06 · Barclays: $83.02026-10-07 · Morgan Stanley: $75.02026-10-08 · UBS: $88.0
$40.0$60.0$80.0NovFebMayAug

Each firm's latest target

last 90 days · 7 firms
DateFirmTargetPreviousChangeVs price thenVs price now
2026-10-08UBS$88.00$77.00▲ 14%+22%+27%
2026-10-07Morgan Stanley$75.00$66.00▲ 14%+5%+8%
2026-10-06Barclays$83.00$82.00▲ 1%+14%+19%
2026-09-09Bernstein$47.00$58.50▼ 20%-39%-32%
2026-07-24RBC Capital$73.00——+18%+5%
2026-07-24Wells Fargo$70.00$77.00▼ 9%+10%+1%
2026-07-23BMO Capital$78.00$47.00▲ 66%+25%+12%

Consensus estimates

revenue and EPS by fiscal year · reported years marked
FYRevenueYoYEPSYoYRevenue rangeEPS rangeAnalysts
2023reported$22.7B-2%——est. $22.8B-1%est. $1.4810
2024reported$25.2B+11%——est. $25.6B-2%est. $1.4111
2025reported$25.2B+0%——est. $25.5B-1%est. $1.5511
2026$29.8B+18%$3.13+102%$27.8B–$33.6B$2.33–$3.6813
2027$36.2B+21%$4.26+36%$30.7B–$41.7B$2.56–$5.6313
2028$37.9B+5%$4.75+11%$32.5B–$47.0B$2.38–$6.0314
2029$41.8B+10%$4.80+1%$37.3B–$47.9B$4.14–$5.728
2030$41.5B-1%$2.77-42%$37.1B–$47.6B$2.39–$3.3012
A reported year shows the company's figures, with the consensus beside it (revenue against it in %). Reported EPS is GAAP diluted; the analysts' EPS usually leaves items such as stock compensation out, so the two are not like for like. Faded: a year the valuation models do not read — they read the first 3, and a later one only while 10 or more analysts cover every year up to it — or one under 5 analysts.

Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.